Statements (61)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:virus
|
| gptkbp:belongs_to |
Paramyxoviridae family
|
| gptkbp:cause |
respiratory infections
|
| gptkbp:clinical_trial |
ongoing
shortness of breath wheezing chest tightness |
| gptkbp:collaborations |
international studies
|
| gptkbp:community_health |
gptkb:significant
|
| gptkbp:complications |
asthma exacerbation
chronic obstructive pulmonary disease |
| gptkbp:data_usage |
high
|
| gptkbp:diagnosis |
serology
PCR testing similarity to other viruses |
| gptkbp:discovery_year |
gptkb:1956
|
| gptkbp:diseases |
gptkb:pneumonia
bronchiolitis |
| gptkbp:distribution |
worldwide
|
| gptkbp:epidemiology |
seasonal outbreaks
|
| gptkbp:funding |
increasing
|
| gptkbp:future_prospects |
long-term immunity
vaccine efficacy |
| gptkbp:genetic_diversity |
high
|
| gptkbp:healthcare |
high
|
| gptkbp:hosts |
gptkb:animals
gptkb:humans |
| https://www.w3.org/2000/01/rdf-schema#label |
Respirovirus
|
| gptkbp:includes |
gptkb:human_respiratory_syncytial_virus
|
| gptkbp:infected_population |
gptkb:children
elderly |
| gptkbp:is_vulnerable_to |
inactivated vaccines
live attenuated vaccines recombinant vaccines no approved vaccine |
| gptkbp:prevention |
vaccination
|
| gptkbp:public_awareness |
low
|
| gptkbp:replaces |
human patients
|
| gptkbp:research_focus |
epidemiological studies
vaccine development pathogenesis |
| gptkbp:risk_factor |
premature birth
underlying health conditions immunocompromised status |
| gptkbp:seasonal_activities |
winter months
|
| gptkbp:seed_dispersal |
single-stranded RNA
|
| gptkbp:symptoms |
cough
fever sore throat nasal congestion 1 to 2 weeks |
| gptkbp:transmission |
airborne droplets
|
| gptkbp:treatment |
supportive care
monoclonal antibodies antiviral medications immune modulation |
| gptkbp:type_of |
gptkb:A
gptkb:C B |
| gptkbp:bfsParent |
gptkb:paramyxovirus
|
| gptkbp:bfsLayer |
6
|